• M Basora, M J Colomina, V Moral, M S Asuero de Lis, E Boix, J L Jover, J V Llau, M P Rodrigo, J Ripollés, and J M Calvo Vecino.
• Anestesiología y Reanimación, Hospital Clínic, Barcelona, España. Electronic address: mbasora@clinic.ub.es.
• Rev Esp Anestesiol Reanim. 2016 Jan 1; 63 (1): 29-47.

AbstractThe present Clinical practice guide responds to the clinical questions about security in the choice of fluid (crystalloid, colloid or hydroxyethyl starch 130) in patients who require volume replacement during perioperative period of non-cardiac surgeries. From the evidence summary, recommendations were made following the GRADE methodology. In this population fluid therapy based on crystalloids is suggested (weak recommendation, low quality evidence). In the events where volume replacement is not reached with crystalloids, the use of synthetic colloids (hydroxyethyl starch 130 or modified fluid gelatin) is suggested instead of 5% albumin (weak recommendation, low quality evidence). The choice and dosage of the colloid should be based in the product characteristics, patient comorbidity and anesthesiologist's experience.Copyright © 2015 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Publicado por Elsevier España, S.L.U. All rights reserved.

16 keywords...

hide…